Maria Fernanda Liphaus Almeida Negreli

Gabapentinoid Use and Risk of Alzheimer’s Disease-Related Dementias: A Systematic Review and Meta-analysis of Observational Studies

Anderson Matheus Pereira da Silva, Marianna Leite, Giovana Menegucci, Maria Fernanda Liphaus Almeida Negreli et autres

br, us (code pays fourni par la source)

Baseline epidemiological differences between donanemab and lecanemab users in real-world settings: a retrospective cohort study

Filipi Fim Andreão, Rafael Paletta da Silva, Maria Fernanda Liphaus Almeida Negreli, Ana Beatriz P. Aguiar-Barros et autres

Donanemab and Lecanemab are anti-amyloid monoclonal antibodies recently approved for the treatment of Alzheimer’s disease. Although their efficacy and safety have been investigated in randomized trials, real-world epidemiological data on treated populations remain limited. This study aimed to compare baseline clinical and …

Baseline epidemiological differences between donanemab and lecanemab users in real-world settings: a retrospective cohort study

Filipi Fim Andreão, R S da Silva, Maria Fernanda Liphaus Almeida Negreli, Ana Beatriz P. Aguiar-Barros et autres

Aims Donanemab and Lecanemab are anti-amyloid monoclonal antibodies recently approved for the treatment of Alzheimer’s disease. Although their efficacy and safety have been investigated in randomized trials, real-world epidemiological data on treated populations remain limited. This study aimed to compare baseline clinical …

br (code pays fourni par la source)

Baseline epidemiological differences between donanemab and lecanemab users in real-world settings: a retrospective cohort study

Filipi Fim Andreão, Rafael Paletta da Silva, Maria Fernanda Liphaus Almeida Negreli, Ana Beatriz P. Aguiar-Barros et autres

Donanemab and Lecanemab are anti-amyloid monoclonal antibodies recently approved for the treatment of Alzheimer’s disease. Although their efficacy and safety have been investigated in randomized trials, real-world epidemiological data on treated populations remain limited. This study aimed to compare baseline clinical and …

Acetylation-mediated fluconazole inactivation: A novel antifungal resistance mechanism

Ludmila Gouveia-eufrasio, Gustavo José Cota de Freitas, Danielle Leticia da Silva, Iara Rinco Silva et autres

Antifungal resistance is considered a global health threat. However, enzymatic inactivation of antifungals, a common mechanism seen in antibacterial resistance, has not yet been described in fungi. From a One Health perspective, this study demonstrates that Cryptococcus deuterogattii and C. neoformans, the …

br, us (code pays fourni par la source)

Effects of Deep Brain Stimulation and Botulinum Toxin to Manage Pisa Syndrome in Parkinson's Disease

Thiago M. Silva, Maria Fernanda Liphaus Almeida Negreli, Francisco Cardoso

BACKGROUND: Pisa Syndrome (PS) is an abnormal postural deformity characterized by lateral trunk flexion leading to significant disability in patients with Parkinson's disease (PD). Botulinum toxin (BTX) and deep brain stimulation (DBS) have emerged as potential interventions. OBJECTIVES: To systematically review the …

br (code pays fourni par la source)